Endeavor Biomedicines, Inc. — Form D
Endeavor Biomedicines, Inc. of San Diego, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-02-07. The offering totals $101.0M, of which $89.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-02-07
- Form: D
- Accession: 0001567619-22-002652
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $101.0M
- Amount sold: $89.1M
- Remaining: $11.9M
- Investors: 16
- Date of first sale: 2022-01-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-432641
Issuer
- Name: Endeavor Biomedicines, Inc.
- CIK: 0001909364
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 12707 High Bluff Drive, Suite 300, San Diego, CA, 92130
- Phone: (858) 537-1700
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Raghu Saripalli | Executive Officer | San Diego, CA |
| Bernard Davitian | Director | Chicago, IL |
| Patrick G Enright | Director | San Diego, CA |
| John Hood | Director | San Diego, CA |
| John Hood | Executive Officer | San Diego, CA |
| Vishaal Turakhia | Executive Officer | San Diego, CA |
| Chris Krueger | Executive Officer | San Diego, CA |
| Enoch Kariuki | Executive Officer | San Diego, CA |
| Karan Cheong Takhar | Director | San Diego, CA |
| Miguel de los Rios | Executive Officer | San Diego, CA |
| Monal Cheong Mehta | Director | San Diego, CA |
| Wing Cheong Lam | Director | San Diego, CA |
Other filings by this issuer (1)
More